{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:11:15Z","timestamp":1791277875447,"version":"4.1.0"},"reference-count":45,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2012,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The global emergence of multidrug-resistant tuberculosis has highlighted the need for the development of rapid tests to identify resistance to second-line antituberculosis drugs. Resistance to fluoroquinolones and aminoglycosides develops through nonsynonymous single nucleotide polymorphisms in the\n            <jats:italic>gyrA<\/jats:italic>\n            and\n            <jats:italic>gyrB<\/jats:italic>\n            genes and the\n            <jats:italic>rrs<\/jats:italic>\n            gene, respectively. Using DNA sequencing as the gold standard for the detection of mutations conferring resistance, in conjunction with spoligotyping, we demonstrated heteroresistance in 25% and 16.3% of\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Mycobacterium tuberculosis<\/jats:named-content>\n            isolates resistant to ofloxacin and amikacin, respectively. Characterization of follow-up isolates from the same patients showed that the population structure of clones may change during treatment, suggesting different phases in the emergence of resistance. The presence of underlying mutant clones was identified in isolates which failed to show a correlation between phenotypic resistance and mutation in the\n            <jats:italic>gyrA<\/jats:italic>\n            or\n            <jats:italic>rrs<\/jats:italic>\n            gene. These clones harbored previously described mutations in either the\n            <jats:italic>gyrA<\/jats:italic>\n            or\n            <jats:italic>rrs<\/jats:italic>\n            gene, suggesting that rare mutations conferring resistance to ofloxacin or amikacin may not be as important as was previously thought. We concluded that the absence of a correlation between genotypic and phenotypic resistance implies an early phase in the emergence of resistance within the patient. Thus, the diagnostic utility of genetics-based drug susceptibility tests will depend on the proportion of patients whose bacilli are in the process of acquiring resistance in the study setting. These data have implications for the interpretation of molecular and microbiological diagnostic tests for patients with drug-susceptible and drug-resistant tuberculosis who fail to respond to treatment and for those with discordant results.\n          <\/jats:p>","DOI":"10.1128\/aac.05905-11","type":"journal-article","created":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T04:11:22Z","timestamp":1329192682000},"page":"2420-2427","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":58,"title":["Mycobacterium tuberculosis Population Structure Determines the Outcome of Genetics-Based Second-Line Drug Resistance Testing"],"prefix":"10.1128","volume":"56","author":[{"given":"E. M.","family":"Streicher","sequence":"first","affiliation":[{"name":"DST\/NRF Centre of Excellence for Biomedical Tuberculosis Research\/MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Stellenbosch, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Bergval","sequence":"additional","affiliation":[{"name":"KIT Biomedical Research, Royal Tropical Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Dheda","sequence":"additional","affiliation":[{"name":"Lung Infection and Immunity Unit, Division of Pulmonology and Clinical Immunology, and UCT Lung Institute, Department of Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. C.","family":"B\u00f6ttger","sequence":"additional","affiliation":[{"name":"Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. C.","family":"Gey van Pittius","sequence":"additional","affiliation":[{"name":"DST\/NRF Centre of Excellence for Biomedical Tuberculosis Research\/MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Stellenbosch, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bosman","sequence":"additional","affiliation":[{"name":"National Health Laboratory Service, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Coetzee","sequence":"additional","affiliation":[{"name":"National Health Laboratory Service, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. M.","family":"Anthony","sequence":"additional","affiliation":[{"name":"KIT Biomedical Research, Royal Tropical Institute, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. D.","family":"van Helden","sequence":"additional","affiliation":[{"name":"DST\/NRF Centre of Excellence for Biomedical Tuberculosis Research\/MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Stellenbosch, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. C.","family":"Victor","sequence":"additional","affiliation":[{"name":"DST\/NRF Centre of Excellence for Biomedical Tuberculosis Research\/MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Stellenbosch, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. M.","family":"Warren","sequence":"additional","affiliation":[{"name":"DST\/NRF Centre of Excellence for Biomedical Tuberculosis Research\/MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Stellenbosch, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200709-1436OC"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1164\/rccm.2401001","article-title":"Tuberculosis due to multiple strains: a concern for the patient? A concern for tuberculosis control?","volume":"169","author":"Behr MA","year":"2004","unstructured":"BehrMA. 2004. Tuberculosis due to multiple strains: a concern for the patient? A concern for tuberculosis control? Am. J. Respir. Crit. Care Med. 169:554\u2013555.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00128-10"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907847"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/9783527627905.ch5","volume-title":"AIDS and tuberculosis: a deadly liaison","author":"Bottger EC","year":"2009","unstructured":"BottgerEC SpringerB. 2009. M. tuberculosis: drug resistance and genetic mechanisms\u2014facts, artifacts and fallacies, p 103\u2013121. In KaufmanSHE WalkerBD (ed), AIDS and tuberculosis: a deadly liaison. Wiley Blackwell, Berlin, Germany."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1602.090968"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01550-10"},{"key":"e_1_3_2_9_2","first-page":"301","article-title":"Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs\u2014worldwide, 2000\u20132004","volume":"55","author":"CDC","year":"2006","unstructured":"CDC. 2006. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs\u2014worldwide, 2000\u20132004. MMWR Morb. Mortal. Wkly. Rep. 55:301\u2013305.","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02271-10"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0805644"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(10)60492-8","article-title":"Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study","volume":"375","author":"Dheda K","year":"2010","unstructured":"DhedaK. 2010. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Lancet 375:1798\u20131807.","journal-title":"Lancet"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2010.05.001"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1054\/tube.2000.0278","article-title":"Demonstration of reinfection and reactivation in HIV-negative autopsied cases of secondary tuberculosis: multilesional genotyping of Mycobacterium tuberculosis utilizing IS6110 and other repetitive element-based DNA fingerprinting","volume":"81","author":"du Plessis DG","year":"2001","unstructured":"du PlessisDG WarrenR RichardsonM JoubertJJ van HeldenPD. 2001. Demonstration of reinfection and reactivation in HIV-negative autopsied cases of secondary tuberculosis: multilesional genotyping of Mycobacterium tuberculosis utilizing IS6110 and other repetitive element-based DNA fingerprinting. Tuberculosis (Edinburgh) 81:211\u2013220.","journal-title":"Tuberculosis (Edinburgh)"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69573-1"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00081-09"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00089808"},{"key":"e_1_3_2_18_2","first-page":"119","article-title":"Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain","volume":"14","author":"Johnson R","year":"2010","unstructured":"JohnsonR. 2010. Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain. Int. J. Tuberc. Lung Dis. 14:119\u2013121.","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.4.907-914.1997"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.12.7099-7108.2003"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00201-10"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00061808"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.2.354"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.8.4.496"},{"key":"e_1_3_2_25_2","unstructured":"National Committee for Clinical Laboratory Standards. 2003. Susceptibility testing of mycobacteria norcardiae and other aerobic actinomycetes: approved standard p 1\u201371. NCCLS Wayne PA."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3201\/eid1209.041263","article-title":"Differentiation of tuberculosis strains in a population with mainly Beijing-family strains","volume":"12","author":"Nikolayevskyy V","year":"2006","unstructured":"NikolayevskyyV. 2006. Differentiation of tuberculosis strains in a population with mainly Beijing-family strains. Emerg. Infect. Dis. 12:1406\u20131413.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1086\/522987"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-50-12-1018"},{"key":"e_1_3_2_29_2","first-page":"339","article-title":"Heteroresistance in Mycobacterium tuberculosis","volume":"5","author":"Rinder H","year":"2001","unstructured":"RinderH MieskesKT LoscherT. 2001. Heteroresistance in Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 5:339\u2013345.","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000002"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.12.5528-5536.2004"},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1365-2958.2010.07218.x","article-title":"Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in-vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosis","volume":"70","author":"Shcherbakov D","year":"2010","unstructured":"ShcherbakovD. 2010. Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in-vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosis. Mol. Microbiol. 70:830\u2013840.","journal-title":"Mol. Microbiol."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01916-06"},{"key":"e_1_3_2_34_2","first-page":"100","article-title":"Correlation of mutations detected by INNO-LiPA with levels of rifampicin resistance in Mycobacterium tuberculosis","volume":"120","author":"Srivastava K","year":"2004","unstructured":"SrivastavaK. 2004. Correlation of mutations detected by INNO-LiPA with levels of rifampicin resistance in Mycobacterium tuberculosis. Indian J. Med. Res. 120:100\u2013105.","journal-title":"Indian J. Med. Res."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01429-06"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201101-0056OC"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200503-449OC"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(00)02429-6","article-title":"Classification of drug-resistant tuberculosis in an epidemic area","volume":"356","author":"van Rie A","year":"2000","unstructured":"van RieA. 2000. Classification of drug-resistant tuberculosis in an epidemic area. Lancet 356:22\u201325.","journal-title":"Lancet"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1086\/315054","article-title":"Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling \u201cstrain W\u201d among noninstitutionalized, human immunodeficiency virus-seronegative patients","volume":"180","author":"van Rie A","year":"1999","unstructured":"van RieA. 1999. Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling \u201cstrain W\u201d among noninstitutionalized, human immunodeficiency virus-seronegative patients. J. Infect. Dis. 180:1608\u20131615.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_40_2","first-page":"195","article-title":"Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the Western Cape of South Africa","volume":"11","author":"Victor TC","year":"2007","unstructured":"VictorTC. 2007. Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the Western Cape of South Africa. Int. J. Tuberc. Lung Dis. 11:195\u2013201.","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200305-714OC"},{"key":"e_1_3_2_42_2","unstructured":"WHO. 2008. The global MDR-TB and XDR-TB response plan 2007\u20132008. http:\/\/libdoc.who.int\/hq\/2007\/WHO_HTM_TB_2007.387_eng.pdf. Accessed 1 December 2008."},{"key":"e_1_3_2_43_2","unstructured":"WHO. 2010. Multidrug and extensively drug-resistant TB (M\/XDR-TB) 2010 global report on surveillance and response. http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241599191_eng.pdf. Accessed 26 June 2010."},{"key":"e_1_3_2_44_2","unstructured":"WHO. 2008. WHO media report. New rapid tests for drug-resistant TB for developing countries. http:\/\/www.who.int\/mediacentre\/news\/releases\/2008\/pr21\/en\/index.html. Accessed 9 September 2008."},{"key":"e_1_3_2_45_2","unstructured":"WHO. 2006. WHO media report. WHO Global Task Force outlines measures to combat XDR-TB worldwide. http:\/\/www.who.int\/mediacentre\/news\/notes\/2006\/np29\/en\/index.html. Accessed 4 August 2007."},{"key":"e_1_3_2_46_2","unstructured":"WHO. 2008. Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs. http:\/\/whqlibdoc.who.int\/hq\/2008\/WHO_HTM_TB_2008.392_eng.pdf. Accessed 08 September 2009."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.05905-11","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.05905-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:59:03Z","timestamp":1645480743000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.05905-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.1128\/AAC.05905-11"],"URL":"https:\/\/doi.org\/10.1128\/aac.05905-11","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"2011-10-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-02-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-04-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}